Beta Bionics (BBNX) Net Income towards Common Stockholders (2024 - 2026)

Beta Bionics has disclosed Net Income towards Common Stockholders across 3 years of filings, most recently posting -$21.9 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$21.9 million, down 35.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$66.4 million (down 34.94% YoY), and the FY2025 annual result was -$60.7 million, down 46.94% from the prior year.
• Net Income towards Common Stockholders came in at -$21.9 million for Q1 2026 at Beta Bionics, down from -$13.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$8.3 million in Q1 2024 to a low of -$21.9 million in Q1 2026.
• The 3-year median for Net Income towards Common Stockholders is -$13.5 million (2025), against an average of -$13.8 million.
• Peak annual rise in Net Income towards Common Stockholders reached 11.42% in 2025, while the deepest fall reached 94.92% in 2025.
• Beta Bionics' Net Income towards Common Stockholders stood at -$12.1 million in 2024, then declined by 11.42% to -$13.5 million in 2025, then slumped by 62.59% to -$21.9 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$21.9 million (Q1 2026), -$13.5 million (Q4 2025), and -$14.2 million (Q3 2025), per Business Quant data.